^
Association details:
| Biomarker: | No biomarker |
|---|---|
| Cancer: | B Acute Lymphoblastic Leukemia |
| Drug: | cyclophosphamide (Alkylating agent) + etoposide oral (Topoisomerase II inhibitor, DNA inhibitor) + clofarabine (DNA synthesis inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Excerpt:
REGIMENS FOR RELAPSED OR REFRACTORY Ph-NEGATIVE B-ALL…Other Recommended Regimens...Clofarabine alone or in combination (eg, clofarabine, cyclophosphamide, etoposide)
